About 1,705,944 results (4,321 milliseconds)

SAN FRANCISCANS URGED TO PREPARE FOR COVID-19 AND ...

https://news.google.com/__i/rss/rd/articles/CBMiYmh0dHBzOi8vc2YuZ292L25ld3Mvc2FuLWZyYW5jaXNjYW5zLXVyZ2VkLXByZXBhcmUtY292aWQtMTktYW5kLWluZmx1ZW56YS1ob2xpZGF5LXNlYXNvbi1hcHByb2FjaGVz0gEA?oc=5
Nov 2, 2022 ... While vaccines can reduce these risks, they do not eliminate them. ... SFDPH is also aware of the rising cases of respiratory syncytial virus (RSV) ...

Clinical Overview: Paxlovid for COVID-19

https://news.google.com/__i/rss/rd/articles/CBMiSmh0dHBzOi8vd3d3LnBoYXJtYWN5dGltZXMuY29tL3ZpZXcvY2xpbmljYWwtb3ZlcnZpZXctcGF4bG92aWQtZm9yLWNvdmlkLTE50gEA?oc=5
Jun 16, 2022 ... Paxlovid treats COVID-19 in adults who do not require supplemental oxygen and who are at an increased risk of progression to severe disease.

US11911481B2 - Compositions and methods for treating RSV ...

https://patents.google.com/patent/US11911481B2/en
This invention provides for a RSV-targeted nanoparticle PMN (RTPMN), combining HR2D anti-fusion peptide, and plasmid encoded siRNA against RSV-NS1 and/or ...

Health Care Insights: Six Must-Haves for 2022 and Beyond

https://news.google.com/__i/rss/rd/articles/CBMiWmh0dHBzOi8vd3d3LnBoYXJtYWN5dGltZXMuY29tL3ZpZXcvaGVhbHRoLWNhcmUtaW5zaWdodHMtc2l4LW11c3QtaGF2ZXMtZm9yLTIwMjItYW5kLWJleW9uZNIBAA?oc=5/
Apr 10, 2022 ... Why medication? More than 10,000 medications are available on the market. That's not surprising, given that medicine is the way we treat most ...

EP3324993B1 - Liposomal reduced glutathione for treatment of rsv ...

https://patents.google.com/patent/EP3324993B1/en
But it can also cause bronchitis, croup, and lower respiratory infections like bronchiolitis and pneumonia. Of every 100 infants and young children with RSV ...

US8815295B1 - Anti respiratory syncytial virus peptide ...

https://patents.google.com/patent/US8815295B1/en
RSV also may cause serious disease in immunosuppressed persons, particularly bone marrow transplant patients (Hertz et al., 1989, Medicine 68:269-281). Viral ...

WO2013131182A1 - Guanosine-rich oligonucleotide (gro ...

https://patents.google.com/patent/WO2013131182A1/en
Sep 12, 2013 ... Provided herein is a method of treating Respiratory Syncytial Virus (RSV) infection in a cell. The method involves administering the ...

US5290540A - Method for treating infectious respiratory diseases ...

https://patents.google.com/patent/US5290540A/en
... RSV or PIV3 pneumonia. Since there is no drug currently identified with both antiviral (RSV and PIV3) and anti-inflammatory properties, a combination of a ...

CN103550596A - Application of Anerning granules in preparing ...

https://patents.google.com/patent/CN103550596A/en
... pneumonia medicine, described viral pneumonia is the viral pneumonia that respiratory syncytial virus causes. The application of the peaceful granule of ...

US9738689B2 - Prefusion RSV F proteins and their use - Google ...

https://patents.google.com/patent/US9738689B2/en
... treat RSV infection. ... The high potency of antibodies against antigenic site Ø suggests they could be developed for passive prophylaxis of RSV-induced disease ...